This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


CDC Expands Injection Safety Efforts

More than 150,000 patients have been notified of potential exposure to hepatitis and HIV due to unsafe injection practices in U.S. healthcare settings since 2001. According to the Centers for Disease Control and Prevention (CDC), medical injections are an overlooked source of infections and outbreaks.

To better protect patients from this ongoing problem, the CDC Foundation is partnering with Eli Lilly and Company to support and expand CDC’s Safe Injection Practices Coalition—a group of public health, medical and industry organizations collaborating to raise awareness among patients and healthcare providers about safe injection practices. 
The partnership will extend the reach of Safe Injection Practices Coalition’s One & Only Campaign, an injection safety awareness campaign that has produced and distributed educational and multimedia tools for health care providers and patients. This partnership will also support the expansion of the coalition’s activities, resources and tools for provider training and education, as well as patient empowerment. Funding will also support dissemination of safe injection messages using social media, YouTube, electronic continuing medical education, advertising and print materials for providers and patients. The CDC encourages you to “like” the One & Only Campaign on Facebook today.
Through this three-year partnership with Lilly, CDC will:
• Expand the One & Only Campaign to new audiences such as individual and group-owned physician practices;
• Educate health care providers through new and enhanced training and communication materials to address emerging issues; 
• Improve the Safe Injection Practices Coalition website and social media platforms to share resources and toolkits with new audiences; and
• Engage new and existing Safe Injection Practices Coalition partners.

Source: CDC

comments powered by Disqus